3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase 1/2
2
Phase NA
1
Phase 1
1
Status
Completed
21
Recruiting
9
Unknown
7
Terminated
5
Active not recruiting
4
Withdrawn
3
Not yet recruiting
3
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
1
Interventions
Specimen Handling
4
Educational Status
3
Standard of Care
2
Practice Guidelines as Topic
2
Methods
2
Interviews as Topic
2
Health Promotion
2
Exercise
2
Endoscopic Mucosal Resection
2
Diet Therapy
2
tocilizumab
1
lopinavir-ritonavir drug combination
1
lavender oil
1
jojoba wax
1
gallium 68 PSMA-11
1
azathiopurine
1
apatinib
1
Ultrasonography, Doppler
1
Ultrasonography
1
Transcranial Magnetic Stimulation
1
Tomography, Optical Coherence
1
Self Expandable Metallic Stents
1
Radiosurgery
1
Radiofrequency Ablation
1
Quality of Life
1
Positron-Emission Tomography
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Nutritional Status
1
Nephroureterectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Suspended
×
Bevacizumab
×
Clear all
NCT03743428
2023-06-29
BABST-C
Shenzhen People's Hospital
Phase NA
Suspended
40 enrolled